Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study.
Freyer G, Martinez-Jañez N, Kukielka-Budny B, Ulanska M, Bourgeois H, Muñoz M, Morales S, Calero JB, Cortesi L, Pintér T, Palácová M, Cherciu N, Petru E, Ettl J, de Almeida C, Villanova G, Raymond R, Minh CTT, Rodrigues A, Cazzaniga ME. Freyer G, et al. Among authors: villanova g. Breast. 2024 Apr;74:103681. doi: 10.1016/j.breast.2024.103681. Epub 2024 Feb 9. Breast. 2024. PMID: 38377732 Free PMC article. Clinical Trial.
Randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel in estrogen receptor-positive, HER2-negative patients with advanced breast cancer (NorBreast-231 trial).
Aapro M, Ruiz-Borrego M, Hegg R, Kukielka-Budny B, Morales S, Cinieri S, Freitas-Junior R, Garcia-Estevez L, Szombara E, Borges GS, Passalacqua R, Hervieu H, Groc M, Villanova G. Aapro M, et al. Among authors: villanova g. Breast. 2019 Jun;45:7-14. doi: 10.1016/j.breast.2019.01.009. Epub 2019 Jan 28. Breast. 2019. PMID: 30802822 Clinical Trial.
Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer.
Cinieri S, Chan A, Altundag K, Vandebroek A, Tubiana-Mathieu N, Barnadas A, Dodyk P, Lazzarelli S, Botha M, Rauch D, Villanova G, Coskun U. Cinieri S, et al. Among authors: villanova g. Clin Breast Cancer. 2017 Apr;17(2):91-99.e1. doi: 10.1016/j.clbc.2016.06.014. Epub 2016 Jun 25. Clin Breast Cancer. 2017. PMID: 27756583 Clinical Trial.
Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study.
Steger GG, Dominguez A, Dobrovolskaya N, Giotta F, Tubiana-Mathieu N, Pecherstorfer M, Ardizzoia A, Blasinska-Morawiec M, Espinosa E, Villanova G. Steger GG, et al. Among authors: villanova g. Clin Breast Cancer. 2018 Feb;18(1):e41-e47. doi: 10.1016/j.clbc.2017.05.012. Epub 2017 Jun 27. Clin Breast Cancer. 2018. PMID: 28666812 Clinical Trial.
All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial.
Tubiana-Mathieu N, Bougnoux P, Becquart D, Chan A, Conte PF, Majois F, Espie M, Morand M, Vaissiere N, Villanova G. Tubiana-Mathieu N, et al. Among authors: villanova g. Br J Cancer. 2009 Jul 21;101(2):232-7. doi: 10.1038/sj.bjc.6605156. Epub 2009 Jul 7. Br J Cancer. 2009. PMID: 19584872 Free PMC article. Clinical Trial.
Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial.
Chan A, Martin M, Untch M, Gil MG, Guillem-Porta V, Wojtukiewicz M, Kellokumpu-Lehtinen P, Sommer HL, Georgoulias V, Battelli N, Pawlicki M, Aubert D, Bourlard T, Gasmi J, Villanova G, Petruzelka L; Navelbine Herceptin Project. Chan A, et al. Among authors: villanova g. Br J Cancer. 2006 Oct 9;95(7):788-93. doi: 10.1038/sj.bjc.6603351. Epub 2006 Sep 12. Br J Cancer. 2006. PMID: 16969343 Free PMC article. Clinical Trial.
Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5.
Torres C, Nabaes Jodar M, Acuña D, Montaño RMZ, Culasso ACA, Amadio AF, Aulicino P, Ceballos S, Cacciabue M, Debat H, Dus Santos MJ, Eberhardt MF, Espul C, Fay F, Fernández MA, Fernández F, Muñoz JMF, Ferrini F, Gallego F, Giri AA, Cerri A, Bolatti E, Gismondi MI, Goya S, Gramundi I, Irazoqui JM, König GA, Leiva V, Lucero H, Marquez N, Nardi C, Ortiz B, Pianciola L, Pintos CB, Puebla AF, Rastellini CV, Rojas AE, Sfalcin J, Suárez A, Tittarelli E, Toro R, Villanova GV, Ziehm MC, Zimmermann MC, Zunino S, Proyecto Pais Working Group, Valinotto L, Viegas M. Torres C, et al. Among authors: villanova gv. Viruses. 2023 Jan 22;15(2):312. doi: 10.3390/v15020312. Viruses. 2023. PMID: 36851525 Free PMC article.
Robust and scalable barcoding for massively parallel long-read sequencing.
Ezpeleta J, Garcia Labari I, Villanova GV, Bulacio P, Lavista-Llanos S, Posner V, Krsticevic F, Arranz S, Tapia E. Ezpeleta J, et al. Among authors: villanova gv. Sci Rep. 2022 May 10;12(1):7619. doi: 10.1038/s41598-022-11656-0. Sci Rep. 2022. PMID: 35538127 Free PMC article.
Cost-Effective Method to Perform SARS-CoV-2 Variant Surveillance: Detection of Alpha, Gamma, Lambda, Delta, Epsilon, and Zeta in Argentina.
Torres C, Mojsiejczuk L, Acuña D, Alexay S, Amadio A, Aulicino P, Debat H, Fay F, Fernández F, Giri AA, Goya S, König G, Lucero H, Nabaes Jodar M, Pianciola L, Sfalcin JA, Acevedo RM, Bengoa Luoni S, Bolatti EM, Brusés B, Cacciabue M, Casal PE, Cerri A, Chouhy D, Dus Santos MJ, Eberhardt MF, Fernandez A, Fernández PDC, Fernández Do Porto D, Formichelli L, Gismondi MI, Irazoqui M, Campos ML, Lusso S, Marquez N, Muñoz M, Mussin J, Natale M, Oria G, Pisano MB, Posner V, Puebla A, Re V, Sosa E, Villanova GV, Zaiat J, Zunino S, Acevedo ME, Acosta J, Alvarez Lopez C, Álvarez ML, Angeleri P, Angelletti A, Arca M, Ayala NA, Barbas G, Bertone A, Bonnet A, Bourlot I, Cabassi V, Castello A, Castro G, Cavatorta AL, Ceriani C, Cimmino C, Cipelli J, Colmeiro M, Cordero A, Cristina C, Di Bella S, Dolcini G, Ercole R, Espasandin Y, Espul C, Falaschi A, Fernandez Moll F, Foussal MD, Gatelli A, Goñi S, Jofré ME, Jaramillo J, Labarta N, Lacaze MA, Larreche R, Leiva V, Levin G, Luczak E, Mandile M, Marino G, Massone C, Mazzeo M, Medina C, Monaco B, Montoto L, Mugna V, Musto A, Nadalich V, Nieto MV, Ojeda G, Piedrabuena AC, Pintos C, Pozzati M, Rahhal M, Rechimont C, Remes Lenicov F, Rompato G,… See abstract for full author list ➔ Torres C, et al. Among authors: villanova gv. Front Med (Lausanne). 2021 Dec 10;8:755463. doi: 10.3389/fmed.2021.755463. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34957143 Free PMC article.
36 results